We have administered octreotide, 100 mu g tid, to a 27-year-old man wi
th Nelson's syndrome. After seven days of therapy, adrenocorticotropin
levels fell to 54% of initial values, and some shrinkage of the tumou
r was observed. This study indicates that octreotide therapy may have
a role in the treatment of Nelson's syndrome.